Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104229142 | 10422914 | 2 | F | 20140407 | 20160912 | 20140902 | 20160921 | EXP | US-009507513-1408USA016093 | MERCK | 67.00 | YR | F | Y | 113.40000 | KG | 20160921 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
104229142 | 10422914 | 1 | PS | PRINIVIL | LISINOPRIL | 1 | Oral | 20 MG, BID | Y | 19558 | 20 | MG | TABLET | BID | |||||
104229142 | 10422914 | 2 | SS | CELECOXIB. | CELECOXIB | 1 | Oral | UNK | Y | 0 | |||||||||
104229142 | 10422914 | 3 | SS | CELECOXIB. | CELECOXIB | 1 | Y | 0 | |||||||||||
104229142 | 10422914 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | U | 0 | ||||||||||
104229142 | 10422914 | 5 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | UNK | U | 0 | TABLET | |||||||||
104229142 | 10422914 | 6 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | UNK | U | 0 | ||||||||||
104229142 | 10422914 | 7 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | UNK | U | 0 | ||||||||||
104229142 | 10422914 | 8 | C | ASPIRIN. | ASPIRIN | 1 | UNK | U | 0 | ||||||||||
104229142 | 10422914 | 9 | C | XANAX | ALPRAZOLAM | 1 | UNK | U | 0 | ||||||||||
104229142 | 10422914 | 10 | C | CYCLOBENZAPRINE HYDROCHLORIDE. | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
104229142 | 10422914 | 11 | C | RANITIDINE. | RANITIDINE | 1 | UNK | U | 0 | ||||||||||
104229142 | 10422914 | 12 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | UNK | U | 0 | ||||||||||
104229142 | 10422914 | 13 | C | VENLAFAXINE HYDROCHLORIDE. | VENLAFAXINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
104229142 | 10422914 | 14 | C | METOPROLOL. | METOPROLOL | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
104229142 | 10422914 | 1 | Hypertension |
104229142 | 10422914 | 2 | Osteoarthritis |
104229142 | 10422914 | 3 | Rheumatoid arthritis |
104229142 | 10422914 | 4 | Gastritis prophylaxis |
104229142 | 10422914 | 5 | Hypothyroidism |
104229142 | 10422914 | 6 | Incontinence |
104229142 | 10422914 | 7 | Blood cholesterol increased |
104229142 | 10422914 | 8 | Cardiovascular event prophylaxis |
104229142 | 10422914 | 9 | Anxiety |
104229142 | 10422914 | 10 | Temporomandibular joint syndrome |
104229142 | 10422914 | 11 | Gastrooesophageal reflux disease |
104229142 | 10422914 | 12 | Constipation |
104229142 | 10422914 | 13 | Depression |
104229142 | 10422914 | 14 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
104229142 | 10422914 | HO |
104229142 | 10422914 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
104229142 | 10422914 | Anaphylactic reaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
104229142 | 10422914 | 1 | 2010 | 20140407 | 0 | |
104229142 | 10422914 | 2 | 20130504 | 20130903 | 0 | |
104229142 | 10422914 | 4 | 20130503 | 20130903 | 0 | |
104229142 | 10422914 | 5 | 2013 | 0 | ||
104229142 | 10422914 | 6 | 2003 | 0 | ||
104229142 | 10422914 | 7 | 1998 | 0 | ||
104229142 | 10422914 | 8 | 1998 | 0 | ||
104229142 | 10422914 | 9 | 2003 | 0 | ||
104229142 | 10422914 | 10 | 2006 | 0 | ||
104229142 | 10422914 | 11 | 201309 | 0 | ||
104229142 | 10422914 | 12 | 201307 | 0 | ||
104229142 | 10422914 | 13 | 20131103 | 0 | ||
104229142 | 10422914 | 14 | 201312 | 0 |